Cargando…
Biomonitoring and Biomarkers: Exposure Assessment Will Never Be the Same
Using modern analytical technology, it is now possible to measure almost any chemical present in our bodies. The future role of classical exposure assessment will perhaps be marginalized because biomonitoring programs can directly measure the concentration of chemicals that are present in biologic m...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1552022/ https://www.ncbi.nlm.nih.gov/pubmed/16882516 http://dx.doi.org/10.1289/ehp.8755 |
_version_ | 1782129330968592384 |
---|---|
author | Paustenbach, Dennis Galbraith, David |
author_facet | Paustenbach, Dennis Galbraith, David |
author_sort | Paustenbach, Dennis |
collection | PubMed |
description | Using modern analytical technology, it is now possible to measure almost any chemical present in our bodies. The future role of classical exposure assessment will perhaps be marginalized because biomonitoring programs can directly measure the concentration of chemicals that are present in biologic matrices. Although the concentration of chemicals in the environment will continue to be measured and related to exposure parameters, the prioritization of the national environmental agenda will be dictated by biomonitoring. Recent biomonitoring studies have examined the levels of > 200 chemicals. Biomonitoring data, by themselves, are not informative in helping consumers understand their individual health risk. A major challenge facing those who conduct biomonitoring programs is how to best communicate the information to the public. In this article, we review benefits and challenges, along with select results from the Centers for Disease Control and Prevention’s 2005 National Report on Human Exposure to Environmental Chemicals. We recommend that these data be carefully interpreted, with the goal of establishing baseline exposure information, rather than creating surrogates for conclusions about human health risk. |
format | Text |
id | pubmed-1552022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | National Institute of Environmental Health Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-15520222006-08-29 Biomonitoring and Biomarkers: Exposure Assessment Will Never Be the Same Paustenbach, Dennis Galbraith, David Environ Health Perspect Commentaries & Reviews Using modern analytical technology, it is now possible to measure almost any chemical present in our bodies. The future role of classical exposure assessment will perhaps be marginalized because biomonitoring programs can directly measure the concentration of chemicals that are present in biologic matrices. Although the concentration of chemicals in the environment will continue to be measured and related to exposure parameters, the prioritization of the national environmental agenda will be dictated by biomonitoring. Recent biomonitoring studies have examined the levels of > 200 chemicals. Biomonitoring data, by themselves, are not informative in helping consumers understand their individual health risk. A major challenge facing those who conduct biomonitoring programs is how to best communicate the information to the public. In this article, we review benefits and challenges, along with select results from the Centers for Disease Control and Prevention’s 2005 National Report on Human Exposure to Environmental Chemicals. We recommend that these data be carefully interpreted, with the goal of establishing baseline exposure information, rather than creating surrogates for conclusions about human health risk. National Institute of Environmental Health Sciences 2006-08 2006-04-26 /pmc/articles/PMC1552022/ /pubmed/16882516 http://dx.doi.org/10.1289/ehp.8755 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. |
spellingShingle | Commentaries & Reviews Paustenbach, Dennis Galbraith, David Biomonitoring and Biomarkers: Exposure Assessment Will Never Be the Same |
title | Biomonitoring and Biomarkers: Exposure Assessment Will Never Be the Same |
title_full | Biomonitoring and Biomarkers: Exposure Assessment Will Never Be the Same |
title_fullStr | Biomonitoring and Biomarkers: Exposure Assessment Will Never Be the Same |
title_full_unstemmed | Biomonitoring and Biomarkers: Exposure Assessment Will Never Be the Same |
title_short | Biomonitoring and Biomarkers: Exposure Assessment Will Never Be the Same |
title_sort | biomonitoring and biomarkers: exposure assessment will never be the same |
topic | Commentaries & Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1552022/ https://www.ncbi.nlm.nih.gov/pubmed/16882516 http://dx.doi.org/10.1289/ehp.8755 |
work_keys_str_mv | AT paustenbachdennis biomonitoringandbiomarkersexposureassessmentwillneverbethesame AT galbraithdavid biomonitoringandbiomarkersexposureassessmentwillneverbethesame |